Top 50 Medical Startup Investors in Italy in October 2023

Portfolio highlights

• WORA — Wora is integrated with the main e-commerce platforms. For in-store purchases or via alternative channels (e.g., Instagram, WhatsApp, telephone), they make their app available to retailers to be able to send their requests easily.
• Viceversa — Viceversa provides capital to European digital businesses to support companies in sustainable and ethical growth. The company was founded in 2021 and has locations in Milan and Dublin.
• Resalis Therapeutics — Resalis Therapeutics sviluppa un farmaco in grado di inibire un micro-RNA per il trattamento di alcune malattie metaboliche

Portfolio highlights

• Picosats — PicoSaTs envisages a new generation of telecommunication systems for space applications dedicated to CubeSat pico-satellites. The key technologies at the core of this system are a software defined radio and a highly directive and configurable antenna, operating at higher frequencies (Ka band), and providing very high data rates.
• Leaf Space — Leaf Space aims to become a global leading service provider in the new, emerging microsatellite market by developing a technology platform providing all basic services required by microsatellite operators.
• Energy Dome — Energy Dome | Groundbreaking Long Duration Energy Storage. Using CO2 against climate change. Our Technology enables to store renewable energy efficiently.

Portfolio highlights

• GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
• Renovacor — Renovacor is a preclinical‑stage biopharmaceutical company focused on developing transformative gene therapy‑based treatments for cardiovascular disease.Renovacor’s lead program is a recombinant adeno-associated virus (AAV)‑based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the Bcl2‑associatedathanogene 3 (BAG3) gene.Dilated cardiomyopathy is a condition affecting over 3 million patients in the US and growing steadily. Many patients develop DCM due to ischemic heart disease. Recently subpopulations have been identified that develop DCM due to mutations in specific genes that have been shown to result in the development of DCM. One of these specific genes is the BAG3 gene. The prevalence of disease‑causing BAG3 haploinsufficiency is estimated at approximately 35,000 individuals in the United States, representing an orphan disease by FDA guidelines. It is estimated a similar number of DCM patients with BAG3 mutations exist in Europe. These patients are typically younger and progress to end-stage heart failure sooner than patients with ischemic heart disease. Currently, DCM patients with a BAG3 mutation are treated with standard of care for heart failure. Despite improvements in pharmacotherapy and care, the five‑year survival of a patient with DCM is only 50%. The development of a BAG3 gene replacement therapy for patients with DCM that carry BAG3 mutations could potentially prevent the progression of disease in this otherwise healthy population of young adults.
• BetaGlue Technologies — BetaGlue Technologies engage in the research and offers anticancer products.

Portfolio highlights

• Allotex — Allotex offers therapeutic solutions for the treatment of presbyopia and hyperopia.
• CarThera — Revolutionizing severe brain disease treatments
• Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.

Portfolio highlights

• Ecomate — The ESG Rating platform for every company
• BigProfiles — A deep understanding of customers let a company tailor marketing campaigns and CRM strategies, but companies have only basic data about customers (e.g. gender or age). External data sources like Social Networks, Public Registries and Socio-Demographic data contain rich information about billions of people, like job titles, levels of education,interests and habits.BigProfiles is a Customer Intelligence SAAS that leverages external information about persons to enrich customer profiling: it can profile a company's customers with previously unknown information about them. Thanks to its Identity Resolution algorithm (the result of a PHD), it identifies a person’s information scattered among external sources.Through this technology, BigProfiles provides customer base analytics and behavior predictions: using Artificial Intelligence on enriched profiles allows to predict churn, fraud and willingness to buy.
• Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.

Portfolio highlights

• CellPly — Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based biotherapeutics. The company aims to support the development of novel cancer immunotherapies by accelerating R&D, automating the quality control and advancing theability to monitor the clinical response to these treatments.Through the use of proprietary microfluidic technologies with Co-Culture Array technology, highly-automated analytical instruments and AI-powered image and data analytics, Cellply products define the function of the immune system one cell at a time, combining functional data with other multiplex data and providing unprecedented single-cell analytical solutions.
• GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
• Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.

Portfolio highlights

• NEWTWEN — We develop software that generates real-time embedded digital twin solutions for model predictive control and diagnostics of electromechanical systems, enhancing performance, longevity, and reliability. In essence, our toolchain creates a precise digital replica of a physical device, such as an electric motor or generator, in order to accuratelymodel the electrodynamic and thermodynamic behavior of the system across a wide range of operating conditions. We then apply our proprietary mathematical approach to exponentially reduce the computational complexity of this model—so much so, in fact, that our digital twin can be integrated into the device itself to compute in real-time, “on-chip,” as part of an amazingly fast and accurate firmware solution. By accurately predicting temperatures and other critical system parameters thousands of times per second, our Digital Twin On-Chip solutions not only provide unprecedented insight for real-time control techniques to enhance system performance, but also pave the way for data-as-a-service capabilities such as predictive maintenance, monitoring of component aging, and anomaly detection.
• Coverzen — The digital office of insurers
• Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.

Portfolio highlights

• Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
• Roca Therapeutics — Roca Therapeutics focuses on the research and development of small medicines to treat severe, life-threatening diseases brought on by hypervascularization and the immunosuppression produced by macrophages M2.
• Domain Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression

Portfolio highlights

• AWorld — AWorld is The Sustainability Platform and Mobile App chosen by the United Nations to support the ActNow Campaign.
• Medics — 3D anatomical modeling per la pianificazione pre-operatoria e il supporto intra-operatorio delle chirurgie complesse.
• BionIT Labs — We apply IT to Bionics in order to Turn disabilities into New Possibilities

Portfolio highlights

• CyLock — CyLock anti-hacker is a software designed to defend systems from hacker attacks, identifying weaknesses in their systems and websites, and providing information to address vulnerabilities used by the cybercriminal to access their computers. Through CyLock's Anti-Hacker system, small and medium-sized businesses will be able to test theirdigital defences to identify and eliminate vulnerabilities in websites, e-commerce sites, apps, e-mails, information systems, corporate networks, servers, and IoT. Companies that do not periodically test their digital tools and their staff skills are more exposed to cyber attacks, which turn into business interruptions, document loss, e-commerce, and online payments breakdown.
• Medicud — Medicud develops a device for treating wounds with negative pressure dressing.
• Rocky — Grow your mindset with the AI coaching chat in just 5 minutes of daily self-improvement sessions to be truly successful.

Portfolio highlights

• Easy Rain — We are Easyrain. Continuous innovation runs in our blood.With our expertise, we develop, simulate, and test solutions, launching our ideas into production. We exploit the basic laws of physics to engineer a tangible solution!
• Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
• Alia Therapeutics — Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.

Portfolio highlights

• CellPly — Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based biotherapeutics. The company aims to support the development of novel cancer immunotherapies by accelerating R&D, automating the quality control and advancing theability to monitor the clinical response to these treatments.Through the use of proprietary microfluidic technologies with Co-Culture Array technology, highly-automated analytical instruments and AI-powered image and data analytics, Cellply products define the function of the immune system one cell at a time, combining functional data with other multiplex data and providing unprecedented single-cell analytical solutions.
• Test1 soultions — Test1 Solutions is an oil absorbent technique for hydrocarbons and their derivatives. They serve environmental clean up, oil spill clean up, hydrocarbon spills, geennovation, open cell oleophilic polyurethane foam with a hydrophobic effect, and hydrocarbon spills on water and land.
• Comptek Solutions — Comptek Solutions' novel passivation technology - Kontrox - promotes surface crystalline oxide reconstructions on the surface of the III-V compound semiconductor materials, enabling unprecedented efficiency of devices and a significant reduction in manufacturing costs

Portfolio highlights

• I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.

Portfolio highlights

• KLISBio — KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues.
• ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
• WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.

Portfolio highlights

• I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.

Portfolio highlights

• Cogisen — Cogisen develops artificial intelligence solutions. It offers SENCOGI, an eye-tracking software for smartphones/mobile phones. Chiara Passacantilli and Christiaan Erik Rijnders founded Cogisen in 2009. Its headquarters is in Naples in Italy.
• Directa Plus — Directa Plus is a nanotechnology company, manufactures nanoparticles.
• Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.

Portfolio highlights

• NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
• Repron Therapeutics — Repron Therapeutics provides treatments for solid tumor cases where radical excision is not possible and metastasis or recurrence is extremely likely.
• Resalis Therapeutics — Resalis Therapeutics sviluppa un farmaco in grado di inibire un micro-RNA per il trattamento di alcune malattie metaboliche

Portfolio highlights

• Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.

Portfolio highlights

• I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.

Portfolio highlights

• Dianax — Milan-based Dianax was founded in 2013 starting from a group scientists led by Eugenio Iannone and Maurizio Moroni and by a few angel investors orchestrated by Gabriele Bavagnoli. Dianax mission is to develop and manufacture labs-on-chip aiming to trasform protein-based diagnostics and make it prompt, easy to use, inexpensive and reliableTheDianax novel technology is designed to make precise diagnostic results convenient, easily accessible, and affordable to patients and healthcare professionals, to empower them to effective prevention, ongoing accurate management and timely emergency treatment.The Dianax technology is the first ever application to diagnostics of a combination of microfluidic innovations and electrochemistry detection systems.Dianax was founded by Eugenio Iannone and his partners to pursue technical and market opportunities based on proprietary, independent research.
• Leaf Space — Leaf Space aims to become a global leading service provider in the new, emerging microsatellite market by developing a technology platform providing all basic services required by microsatellite operators.
• WIB Machines — Smart vending machines and smart lockers manufacturer pioneering smart, web-based retail automation globally. Patented solutions enabling next-gen retail.

Portfolio highlights

• ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
• Flynotes — Flynotes is a digital software platform helping dentists deliver personalised patient care
• QV Bioelectronics — Manchester-based start-up QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumours.

Portfolio highlights

• Ossio — OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.
• Nalu Medical — Nalu Medical is an early-stage company that develops a range of medical devices. Their vision to modernize and improve the technology in medical devices, thus improving the lives of people.The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS)and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The company was founded in 2014 and is based in Carlsbad, California.
• Neurolens — 2/3 of patients experience the symptoms of eye misalignment, but relief is in sight with Neurolens using the NMD2 and Neurolenses with Contoured Prism.

Portfolio highlights

• CellPly — Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based biotherapeutics. The company aims to support the development of novel cancer immunotherapies by accelerating R&D, automating the quality control and advancing theability to monitor the clinical response to these treatments.Through the use of proprietary microfluidic technologies with Co-Culture Array technology, highly-automated analytical instruments and AI-powered image and data analytics, Cellply products define the function of the immune system one cell at a time, combining functional data with other multiplex data and providing unprecedented single-cell analytical solutions.

Portfolio highlights

• Macai — Macai offers thousands of high-quality products delivered at your doorstep in a few minutes.Macai is the first Italian company active in the Q-commerce space. Founded by Giovanni Cavallo, serial entrepreneur with a deep background in food delivery, the project is now live in Milan and Turin. Compared to other players in the industry, Macai ismore focused on providing a wider offer than on the speed variable. We aim at building an online full grocer, with more than 7000 skus delivered in less than 45 minutes.
• GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
• Insoore — Insoore is a platform that helps insurance companies to improve the claims management process, thanks to on-demand photographic inspections and damage estimates provided by a community of experts.

Portfolio highlights

• Deka Biosciences — Deka BioSciences, Inc. is committed to developing and delivering life-changing medicines to patients with cancer and inflammatory diseases.
• ReCode Therapeutics — ReCode is the first genetic medicines platform to enable highly targeted delivery to organs, tissues and cells beyond the liver. Our pipeline of rare disease therapeutics uses optimized mRNA and gene correction with redosing capability.
• Arialys Therapeutics — Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience. The company focuses on how the immune system impacts CNS health, disease, and treatment.

Portfolio highlights

• GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.

Portfolio highlights

• DAXOR — DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential totransform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility.The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.
• Preteckt — Preteckt offers cloud-based vehicle prognostics powered by AI to support all fleet vehicle types while delivering the world's highest precision repair plans. Get to the root cause 40% faster.
• Branch Technology — Patented 3D-printed fabrication technology combining additive manufacturing, prefabrication, and digital technology at construction scale, with true design freedom.

Portfolio highlights

• MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
• Vivasure Medical — Medical device company developing a closure device for vascular access procedures.
• Ermium Therapeutics — Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases, based on a breakthrough discovery showing that CXCR4 is a master regulator of inflammation.

Portfolio highlights

• Convivit — Convivit develops a residential and hotel services platform that creates a network of self-sufficient senior living residences. Convivit is a joint venture between Generali Italia and CDP Venture Capital SGR, created with the aim of introducing senior living in Italy and promoting people's well-being and active aging.
• Neuranix — Neuranix develops, manufactures, and markets innovative devices for the diagnosis of ear diseases in the medical and veterinary fields. They own several patents in the audiological field. They create products based on the analysis of the acoustic characteristics of the eardrum and middle ear measured over a broad spectrum of frequencies. Theysupport the diagnosis and monitor the therapy of middle ear pathologies.
• Rubber Conversion — Rubber Conversion provides recycling, product sustainability, custom packaging, environmental impact analysis, material tracking, and online document management. Their customers contact them through phone, email, and online applications.

Portfolio highlights

• NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
• Prestatech — Prestatech is a digital credit factory that has developed an innovative underwriting platform for banks and financial institutions in Europe. Currently active with major European banks, Prestatech offers them a variety of digital credit services from data enrichment to end-to-end instant lending solutions. Thanks to technological innovation,Prestatech has gained an extensive expertise in the digital credit space and through its open-platform is currently offering API-based solutions that leverage on AI, advanced algorithms and Big Data technologies.
• Chiara Ferragni — COM Chiara Ferragni

Portfolio highlights

• Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ​ Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
• Bio4Dreams — Il primo incubatore italiano certificato di startup innovative in fase very early stage, a capitale totalmente privato, dedicato alle Scienze della Vita.

Portfolio highlights

• BetaGlue Technologies — BetaGlue Technologies engage in the research and offers anticancer products.

Portfolio highlights

• GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.

Portfolio highlights

• GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.

Portfolio highlights

• Apron — Sort, pay and reconcile your invoices in seconds.
• Worldover — Cosmetic compliance made simple
• Class Companion — Class Companion is a new AI technology that allows professors to provide students with immediate, individualized feedback.

Portfolio highlights

• GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.

Portfolio highlights

• Pedius — Pedius is a communication system that allows deaf people to make normal phone calls. Use it in your everyday life to make important calls such as booking doctors appointments or making reservations, or to call family, friends and coworkers.Once you download the smartphone app you can start a conversation by either typing or speaking a message.The recipient will listen on their end and reply, and you will immediately read a transcription of what he or she just said. Pedius gives you the freedom to have real-time conversations when you need to call a plumber, book a table at your favourite restaurant, or talk to your doctor.The Pedius app is especially useful when you need to contact someone accessible only by phone, and it is an excellent help when you need to be careful about your privacy.
• Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.

Portfolio highlights

• D-EYE — D-EYE's technology enables healthcare professionals all over the world to quickly screen for problems, photograph them and then distribute them digitally via various secure wireless solutions. They design and manufacture diagnostic instruments.

Portfolio highlights

• Piantando — Piantando sells plants connected to initiatives for the preservation of the planet engaged in the following areas: land, water, climate, biodiversity and local communities. Each plant is equivalent to a transparent and unique contribution, destined to an initiative certified by our Value Chain. Everyone become ambassadors of a new way of livinggreen and understanding their commitment to the planet.
• FrescoFrigo - Healthy food close to you — FrescoFRIGO is a smart fridge with fresh and quality products designed for the needs of worker. Improve everyday lifestyle, through automated proximity selling of good, fresh and healthy product, innovating technology and user experience.
• The Nemesis — The Nemesis is the Metaverse for the mass market: virtual worlds, adventures, gaming Play & Earn and amazing experiences.

Portfolio highlights

• Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
• Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
• Storm Therapeutics — Targeting pathways that modify RNA to deliver novel cancer therapeutics.

Portfolio highlights

• I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.
• Reasoned Art — Reasoned Art is the Italian gallery dedicated to CryptoArt. it selects the best digital artists worldwide, curates physical and virtual exhibitions, and certifies the authenticity of works allowing their sale through NFT.

Portfolio highlights

• Hazy — Hazy is a UCL AI spin out backed by Microsoft and Nationwide. Our core product is synthetic data - data generated artificially using machine learning techniques, that retains the statistical properties of the real data and can be safely used for analytics and innovation without compromising customers privacy and confidential information. We do itby capturing patterns in the raw data to generate completely synthetic 'hazy' data that maintains the statistical value of the original. This means businesses can unlock their data for innovation freely with safer and faster data provisioning on demand and no compliance, security or privacy risks and procurement delays.
• xFarm Technologies — The agricultural business is becoming more and more complex due to legal requirements and product certification. On the other hand, technologies evolve and create opportunity. xFarm is a startup that aims at the digitization of agriculture, providing innovative tools that can support farmers and food supply chain's stakeholders in themanagement of their companies. Created by farmers and tailored to the agricultural sector, its main focus is on ease of use, intuitiveness and complete adaptability to agricultural realities. The digital ecosystem includes a free agricultural application, available on both mobile and desktop and integrated with advanced premium modules, a dashboard Analytics dedicated to professionals and a line of IoT sensors selected, optimized and connected by xFarm.
• Energy Dome — Energy Dome | Groundbreaking Long Duration Energy Storage. Using CO2 against climate change. Our Technology enables to store renewable energy efficiently.

Portfolio highlights

• Vianode — Vianode is a producer of sustainably engineered battery materials.
• Devnya Cement — Devnya Cement is a cement company that operates in the wholesale construction products industry.
• Angelini Pharma — Angelini is committed to identifying health solutions with a prevalent focus on the areas of Central Nervous System (CNS), including pain, and Rare Diseases. The Company is also a leading player in the Consumer Health sector,

Portfolio highlights

• D-EYE — D-EYE's technology enables healthcare professionals all over the world to quickly screen for problems, photograph them and then distribute them digitally via various secure wireless solutions. They design and manufacture diagnostic instruments.

Portfolio highlights

• AGADE — AGADE specialising in robotic exoskeletons. The company created its first product, AGADEXO, which can significantly reduce muscle fatigue and the risk of injury associated with repetitive and dynamic activities. They provide variable support, eliminating the effect of gravity on human limbs and allowing movements comparable to those possible in azero-g environment.
• BroadBit Batteries — BroadBit is a technology company developing revolutionary new batteries using novel sodium-based chemistries to power the future green economy.
• Aenitis Technologies — We develop innovative devices for cells therapy processing using Acoustic Radiation Forces.

Portfolio highlights

• Biorfarm — Adotta il tuo Albero, crea il tuo Campo Digitale e ricevi a domicilio la tua frutta biologica. Solo con Biorfarm puoi seguire la crescita dei tuoi frutti!
• EvenFi — Criptalia uses blockchain technology to connect businesses that have projects to be funded with people and organizations who are looking for high-yield investments. We offer an online platform where companies publish their innovative ideas and industrial improvement projects. Investors, people, and institutions can fund these projects by lendingmoney in exchange for a higher interest rate.
• Latitudo40 — We transform satellite images into useful insights, using AI & ML.

Portfolio highlights

• Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
• Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
• Ariceum Therapeutics — Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.

Portfolio highlights

• 4MDG — 4MDG focuses on providing various data management services such as registration portal, retail technology and customer registration.
• Dubit — Choose your path in the Metaverse.
• CellPly — Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based biotherapeutics. The company aims to support the development of novel cancer immunotherapies by accelerating R&D, automating the quality control and advancing theability to monitor the clinical response to these treatments.Through the use of proprietary microfluidic technologies with Co-Culture Array technology, highly-automated analytical instruments and AI-powered image and data analytics, Cellply products define the function of the immune system one cell at a time, combining functional data with other multiplex data and providing unprecedented single-cell analytical solutions.

Portfolio highlights

• Vino.com — The best red wines, white wines, sparkling wines, champagne, franciacorta and spirits. Vino.com is the most loved online wine shop in Italy. Famous Italian and international wines for sale.
• Winmedical — WinMedical brings to the market a modular, scalable and easy to use platform to continuously monitor vital signs of the Patient in hospital and at home: WINPACK.WinPack is the leading wearable modular device for real-time, continuous and simultaneous vital signs monitoring in non-critical care units and at home, offering: Continuous NonInvasive Blood Pressure – cNIPB, 5-Lead ECG, Heart Rate, Pulse Rate, SpO2, Body Temperature, Posture, and Respiration Rate. It is comfortable to wear, easy to use and lightweight. WinPack’s sensor modules enable monitoring of vital signs via Bluetooth or Wi-Fi while customizable alert settings allow early detection of Patient deterioration.WinPack keeps Patients continuously monitored by the medical staff - anytime and anywhere, whether in hospital or at home while offering an effective cost-reduction solution to healthcare providers.WinPack is the first customizable hardware and software solution for any hospital department, and delivers an increase in efficiency and effectiveness of clinical workflows. WinPack has been proven to generate costs savings and increase clinical efficiency for hospitals through several case studies, as well as through its use in hospital departments including: General Medicine, Haematology, Infectious Diseases, Pneumatology, Nuclear Medicine, Oncology, Post Surgical, Gastroenterology and Internal Medicine.WinPack allows:-> Better Patient care-> Valuable cost reductions for healthcare providers-> Significant reduction of clinical risks-> Considerable reduction of the medical professional liability and litigation risks-> Seamless continuum of care from hospital to home through better care coordination and clinical collaboration By connecting doctors, Nurses and Patients, WinPack improves the quality and turnaround time of the care of adults, infants and paediatric Patients in hospital and at home whether in bed or out of bed. Doctors and Nurses may access Patient’s data at anytime using our user friendly software solution on their PCs, Notebooks, Tablets and Smartphones.
• Parking My Car — Parking My Car offers transportation services.

Portfolio highlights

• Medyria — Medyria is a Swiss medtech startup that engineers technologies for cardiovascular catheter navigation and sensing. They develop a unique guiding and sensing medical device based on proprietary Blood Flow Velocity Sensor technology. The TrackCath System is designed to be cost-effective and safe during EVAR procedures.Medyria's goal is todevelop devices that enable safer and more effective endovascular procedures. It was founded in 2014 and is based in Winterthur, Zurich, Switzerland.
• Terapet — Terapet was founded at CERN by two physicists – Christina Vallgren and Marcus Palm – along with Professor Raymond Miralbell from the Geneva University Hospitals (HUG). They have already proven the feasibility of their concept and are now developing an initial version for market launch.
• CV Lab — CV Lab is the first incubator fully focused on cardiovascular innovation in Europe. It supports the most promising ideas through patenting, prototyping, and proof of concept until they mature enough to give life to a spin-off and meet international capitals. CVLab puts to good use the experience of entrepreneurs and specialists with strongexpertise in biomedical. The company collaborates with experts in the field. CVLab is a lean organization, close to researchers and clinical needs.